Search by Drug Name or NDC
NDC 00135-0098-26 Gaviscon 160; 105 mg/1; mg/1 Details
Gaviscon 160; 105 mg/1; mg/1
Gaviscon is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE.
Product Information
| NDC | 00135-0098 |
|---|---|
| Product ID | 0135-0098_1f37dcea-c641-435b-9d54-efa7f283481a |
| Associated GPIs | 48990002150520 |
| GCN Sequence Number | 019663 |
| GCN Sequence Number Description | magnesium carb/aluminum hydrox TAB CHEW 105-160MG ORAL |
| HIC3 | D4B |
| HIC3 Description | ANTACIDS |
| GCN | 64114 |
| HICL Sequence Number | 001173 |
| HICL Sequence Number Description | MAGNESIUM CARBONATE/ALUMINUM HYDROXIDE |
| Brand/Generic | Brand |
| Proprietary Name | Gaviscon |
| Proprietary Name Suffix | Extra Strength |
| Non-Proprietary Name | aluminum hydroxide and magnesium carbonate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 160; 105 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part331 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00135-0098-26 (00135009826)
| NDC Package Code | 0135-0098-26 |
|---|---|
| Billing NDC | 00135009826 |
| Package | 100 TABLET, CHEWABLE in 1 BOTTLE (0135-0098-26) |
| Marketing Start Date | 2011-06-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |